Skip to main content

Diabetes Type II Pediatric ACHIEVE-PEDS J2A-MC-GZGY

Status: Coming Soon

Study details

View study details on clinicaltrials.gov.

Locations

  • Sacramento

Clinical trial FAQs

Information for patients and study volunteers, including frequently asked questions.

A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Once-Daily Oral Orforglipron Compared With Once-Weekly Dulaglutide in Pediatric Participants 10 to Less Than 18 Years of Age With Type 2 Diabetes

Sub-Investigator

Ulhas M Nadgir, M.D.

Related clinical trials

View all clinical trials

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?